Hepatitis C Virus
Scientists at University of Berlin target hepatitis C virus
Published in Hepatitis Weekly, September 21st, 2009
"Four hundred thirty-three patients were randomly assigned to receive either 1.5 mu g/kg peginterferon alfa-2b weekly plus 800-1,400 mg ribavirin daily for 48 weeks (n = 225, group A) or an individually tailored treatment duration (18-48 weeks; n = 208, group B). In the latter group, treatment duration was calculated using the time required to induce HCV...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2009-09-21)
More Articles from Hepatitis Weekly
- University of North Carolina School of Medicine
Gene variant heightens risk of severe liver disease in cystic fibrosis - Cirrhosis
Studies from University of Michigan, Medical Department update current data on cirrhosis - Hepatitis
Data on hepatitis detailed by R.M. Scott and co-authors - Hepatitis B Virus
New hepatitis B virus data have been reported by S.M. Zou and co-authors - Hepatitis B Virus
Recent findings in hepatitis B virus described by X.Y. Zhang and colleagues - Hepatitis B Virus
Recent studies from Zhejiang University add new data to hepatitis B virus - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
